Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1828 1
1878 1
1893 1
1935 1
1936 1
1941 3
1942 2
1943 2
1944 1
1945 4
1946 16
1947 32
1948 41
1949 22
1950 137
1951 99
1952 43
1953 40
1954 52
1955 57
1956 58
1957 57
1958 54
1959 48
1960 52
1961 54
1962 58
1963 61
1964 61
1965 63
1966 69
1967 62
1968 66
1969 81
1970 106
1971 106
1972 152
1973 134
1974 147
1975 289
1976 295
1977 354
1978 378
1979 395
1980 371
1981 441
1982 447
1983 482
1984 494
1985 552
1986 554
1987 604
1988 594
1989 679
1990 739
1991 741
1992 840
1993 955
1994 938
1995 1030
1996 1013
1997 1089
1998 1127
1999 1145
2000 1155
2001 1234
2002 1406
2003 1492
2004 1664
2005 1939
2006 2143
2007 2311
2008 2524
2009 2794
2010 3183
2011 3785
2012 4263
2013 4979
2014 5690
2015 6237
2016 6632
2017 7020
2018 7655
2019 8451
2020 9934
2021 11502
2022 11635
2023 12074
2024 5454

Text availability

Article attribute

Article type

Publication date

Search Results

130,777 results

Results by year

Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease.
Maurice J, Manousou P. Maurice J, et al. Clin Med (Lond). 2018 Jun;18(3):245-250. doi: 10.7861/clinmedicine.18-3-245. Clin Med (Lond). 2018. PMID: 29858436 Free PMC article. Review.
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of about 25%. Incidence is increasing with rising levels of obesity, type 2 diabetes and the metabolic syndrome, and NAFLD is predicted to become the leading cause of cirrhosis requiring liver transpl …
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of about 25%. Incidence is increasing with rising levels of …
Nonalcoholic fatty liver disease: another leap forward.
Abdelmalek MF. Abdelmalek MF. Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):85-86. doi: 10.1038/s41575-020-00406-0. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33420415 Free PMC article. Review.
In 2020, there have been substantial advances in nonalcoholic fatty liver disease mechanisms, diagnostics and treatment. Key developments include the identification of a cellular and tissue signature to provide new insights into pathophysiology, advancements in non- …
In 2020, there have been substantial advances in nonalcoholic fatty liver disease mechanisms, diagnostics and treatment. Key d …
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
Cotter TG, Rinella M. Cotter TG, et al. Gastroenterology. 2020 May;158(7):1851-1864. doi: 10.1053/j.gastro.2020.01.052. Epub 2020 Feb 13. Gastroenterology. 2020. PMID: 32061595 Review.
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide prevalence of 25%. ...Considering the ongoing obesity epidemic beginning in childhood, the rise in diabetes, and other factors, the prevalence of NAFLD along wi …
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide prevalence of 25%. . …
Non-alcoholic fatty liver disease: Definition and subtypes.
Han SK, Baik SK, Kim MY. Han SK, et al. Clin Mol Hepatol. 2023 Feb;29(suppl):S5-S16. doi: 10.3350/cmh.2022.0424. Epub 2022 Dec 28. Clin Mol Hepatol. 2023. PMID: 36577427 Free PMC article. Review.
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of approximately 30%. ...The rising prevalence of obesity in both the adult and pediatric populations is projected to consequently continue increas …
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of appr …
Mediterranean diet and nonalcoholic fatty liver disease.
Anania C, Perla FM, Olivero F, Pacifico L, Chiesa C. Anania C, et al. World J Gastroenterol. 2018 May 21;24(19):2083-2094. doi: 10.3748/wjg.v24.i19.2083. World J Gastroenterol. 2018. PMID: 29785077 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease, and is characterized by a wide spectrum of fat-liver disorders that can result in severe liver disease and cirrhosis. ...
Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease, and is characteri …
Nonalcoholic Fatty Liver Disease.
Wang XJ, Malhi H. Wang XJ, et al. Ann Intern Med. 2018 Nov 6;169(9):ITC65-ITC80. doi: 10.7326/AITC201811060. Ann Intern Med. 2018. PMID: 30398639 Review.
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. ...Cardiovascular disease is the leading cause of death in patients with nonalcoholic fatty liver disease. Persons with nonalcoholic steatohepatitis h …
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. ...Cardiovascular diseas …
Fatty Liver Disease: Diagnosis and Stratification.
Saiman Y, Duarte-Rojo A, Rinella ME. Saiman Y, et al. Annu Rev Med. 2022 Jan 27;73:529-544. doi: 10.1146/annurev-med-042220-020407. Epub 2021 Nov 22. Annu Rev Med. 2022. PMID: 34809436 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) is a major public health crisis affecting approximately 25% of the world's population. The spectrum of NAFLD ranges from bland steatosis to steatohepatitis with fibrosis; eventual development of cirrhosis in a subgroup of pat …
Nonalcoholic fatty liver disease (NAFLD) is a major public health crisis affecting approximately 25% of the world's population …
Non-alcoholic fatty liver disease.
Neuschwander-Tetri BA. Neuschwander-Tetri BA. BMC Med. 2017 Feb 28;15(1):45. doi: 10.1186/s12916-017-0806-8. BMC Med. 2017. PMID: 28241825 Free PMC article. Review.
Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. As the burden of hepatitis C abates over the next decade, non-alcoholic fatty liver d …
Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in diagnosis, complex p …
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
Carr RM, Oranu A, Khungar V. Carr RM, et al. Gastroenterol Clin North Am. 2016 Dec;45(4):639-652. doi: 10.1016/j.gtc.2016.07.003. Epub 2016 Oct 13. Gastroenterol Clin North Am. 2016. PMID: 27837778 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) is an important cause of morbidity and mortality worldwide and is rapidly becoming the leading cause of end-stage liver disease and liver transplant. ...
Nonalcoholic fatty liver disease (NAFLD) is an important cause of morbidity and mortality worldwide and is rapidly becoming th …
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V, Handa P, Kowdley KV. Manne V, et al. Clin Liver Dis. 2018 Feb;22(1):23-37. doi: 10.1016/j.cld.2017.08.007. Epub 2017 Oct 18. Clin Liver Dis. 2018. PMID: 29128059 Review.
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver disorders ranging from hepatic steatosis to nonalcoholic steatohepatitis (NASH) and ultimately may lead to cirrhosis. ...Fatty liver can progress to NASH in a significant proportion of subjects …
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver disorders ranging from hepatic steatosis to nonalcoho …
130,777 results
You have reached the last available page of results. Please see the User Guide for more information.